Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Methotrexate in Newly Diagnosed Glioblastoma Multiforme
NCT00082797Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Jul 2005
- Primary completion
- May 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methotrexate in glioblastoma multiforme (GBM), sponsored by Eastern Cooperative Oncology Group. Primary endpoint: Response Rate (Complete and Partial). Started Jul 2005; status: completed.
02
Drugs
methotrexate
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00082797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082797.